Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 09, 2021

SELL
$62.61 - $71.29 $16,654 - $18,963
-266 Closed
0 $0
Q4 2019

Feb 05, 2020

SELL
$36.66 - $41.78 $34,607 - $39,440
-944 Reduced 78.02%
266 $11,000
Q3 2019

Nov 12, 2019

BUY
$34.82 - $39.26 $9,053 - $10,207
260 Added 27.37%
1,210 $46,000
Q2 2019

Aug 08, 2019

SELL
$36.05 - $42.76 $15,970 - $18,942
-443 Reduced 31.8%
950 $36,000
Q4 2018

Feb 08, 2019

SELL
$31.89 - $38.44 $36,163 - $43,590
-1,134 Reduced 44.88%
1,393 $51,000
Q3 2018

Nov 13, 2018

BUY
$29.25 - $36.73 $15,414 - $19,356
527 Added 26.35%
2,527 $87,000
Q2 2018

Aug 09, 2018

BUY
$28.49 - $35.06 $39,886 - $49,084
1,400 Added 233.33%
2,000 $64,000
Q1 2018

May 02, 2018

BUY
$31.93 - $39.54 $19,158 - $23,724
600 New
600 $20,000

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.6B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.